Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin Nasal Spray in Idiopathic Rhinitis
NCT02288156Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jul 2015
- Primary completion
- Dec 2018
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of capsaicin 8% patch in idiopathic rhinitis (NAR) (4 arms), sponsored by UZ Leuven. Primary endpoint: Change in Visual Analogue Scale for Major Nasal Symptoms at 4 weeks. Started Jul 2015; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
idiopathic rhinitis (NAR)
Beyond the preview
Go deeper on NCT02288156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02288156.